glutathione pulmonary hypertension Oxidative Stress and Antioxidant Therapy in Immunotherapy of Endothelin-1 Receptor Type
Immunotherapy of Endothelin 1 Receptor Type A for Pulmonary Arterial Hypertension JACC Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes The molecular targets of approved treatments for pulmonary arterial hypertension Thorax Mechanisms of disease: pulmonary arterial hypertension Nature Reviews Cardiology Frontiers Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




